Susquehanna Fundamental Investments’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-8
Closed -$74K 1697
2021
Q2
$74K Sell
8
-29
-78% -$268K ﹤0.01% 1596
2021
Q1
$320K Buy
37
+15
+68% +$130K 0.01% 1276
2020
Q4
$164K Sell
22
-5
-19% -$37.3K ﹤0.01% 1383
2020
Q3
$180K Buy
27
+14
+108% +$93.3K 0.01% 1214
2020
Q2
$94K Buy
+13
New +$94K ﹤0.01% 909